AzurRx BioPharma Inc News - AZRX

AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpointsStudy data...

AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819

BOCA RATON, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”...

Quarterly Report (10-q)

0001604191false--12-31Q22021false0.00012500000000.00010.0001519557000677277402774021008253122538403118698392320919739632020-07-0604500000.01000...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”...

AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”...

AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares

BOCA RATON, Fla., July 27, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the...

Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)

Free Writing Prospectus dated July 22, 2021 Filed pursuant to Rule 433 Relating to the...

AzurRx BioPharma Increases Previously Announced Bought Deal to $5.0 Million

BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the...

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

Filed Pursuant to Rule 424(b)(5) Registration No. 333-256476...

AzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock

BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the...

New To The Street / Newsmax TV Announces 6 Interviews For This Weeks’ 199th TV Broadcast, Sunday, July 18, 2021, Hour Slot ...

NEW YORK, July 16, 2021 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street / Newsmax TV announces its TV...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AzurRx BioPharma Inc (AZRX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

AZRX News

AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819

Quarterly Report (10-q)

Current Report Filing (8-k)

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Current Report Filing (8-k)

AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares

Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)

AzurRx BioPharma Increases Previously Announced Bought Deal to $5.0 Million

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

AzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock

New To The Street / Newsmax TV Announces 6 Interviews For This Weeks’ 199th TV Broadcast, Sunday, July 18, 2021, Hour Slot ...

Statement of Changes in Beneficial Ownership (4)

AZRX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AzurRx BioPharma Inc (AZRX) News

AzurRx BioPharma Inc (AZRX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

AZRX News

AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819

Quarterly Report (10-q)

Current Report Filing (8-k)

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Current Report Filing (8-k)

AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares

Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)

AzurRx BioPharma Increases Previously Announced Bought Deal to $5.0 Million

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

AzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock

New To The Street / Newsmax TV Announces 6 Interviews For This Weeks’ 199th TV Broadcast, Sunday, July 18, 2021, Hour Slot ...

Statement of Changes in Beneficial Ownership (4)

AZRX Discussion

Your Recent History